Clinical Trials Logo

Clinical Trial Summary

Up to 500 subjects undergoing standard endoscopy / pouchoscopy, or having ileostomy or colostomy bags or having an ileal pouch and who meet the eligibility criteria will be enrolled to this study during up to three years at up to 4 clinical sites. GI fluids samples will be collected from: (i) fluids suctioned during standard endoscopy procedures / pouchoscopy, (ii) from ileostomy/colostomy bags removed for bag replacement and (iii) from stool samples collected by patients after pouch surgery.


Clinical Trial Description

Up to 500 subjects undergoing standard endoscopy / pouchoscopy, or having ileostomy or colostomy bags or having an ileal pouch and who meet the eligibility criteria will be enrolled to this study during up to three years at up to 4 clinical sites. GI fluids samples will be collected from: (i) fluids suctioned during standard endoscopy procedures / pouchoscopy, (ii) from ileostomy/colostomy bags removed for bag replacement and (iii) from stool samples collected by patients after pouchsurgery.

The samples will be collected into sealed plastic containers, clearly labeled with "Biohazard" stickers and patient's code and be kept on ice for up to 30min and then freezed in -20deg to -80deg.

Characterization and quanification of small molecules- and protein biomarkers of GI diseases such as IBD will be performed. ;


Study Design


Related Conditions & MeSH terms

  • Chronic Inflammatory Small Bowel Disease

NCT number NCT02797535
Study type Interventional
Source Medtronic - MITG
Contact
Status Completed
Phase N/A
Start date July 2016
Completion date February 7, 2019

See also
  Status Clinical Trial Phase
Completed NCT02742714 - PillCam SBC System Functionality in Established and Suspected IBD Patients N/A
Enrolling by invitation NCT06189599 - Modified antioxIdants Bacteria for Gut Inflammation
Terminated NCT04032756 - Tofacitinib Registry of Patients With Ulcerative Colitis in Germany